Market Overview

The Medicines Company (NASDAQ: )

0.00 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2019
Pre-Market
EPS:
REV:
-0.70
-3.30M

-0.72
0

Q2 2019
Pre-Market
EPS:
REV:
-0.63
1.667M
-0.73
970K
-0.63
0
13.7%
-100%
Q1 2019
Pre-Market
EPS:
REV:
-0.76
7.771M
-0.58
2.47M
-0.62
0
-6.9%
-100%
Q4 2018
Pre-Market
EPS:
REV:
-0.61
8.595M
-0.61
3.18M
-0.62
1.64%
-100%
Q3 2018
Pre-Market
EPS:
REV:
-1.19
16.871M
-0.55
3.23M
-0.70
-3.30M
27.27%
-202.17%
Q2 2018
Pre-Market
EPS:
REV:
-1.02
18.742M
-0.60
7.31M
-0.63
1.667M
5%
-77.2%
Q1 2018
Pre-Market
EPS:
REV:
-1.05
24.216M
-0.78
7.99M
-0.76
7.771M
-2.56%
-2.74%
Q4 2017
Pre-Market
EPS:
REV:
-1.19
25.199M
-1.28
22.67M
-0.61
8.595M
-52.34%
-62.09%
Q3 2017
Pre-Market
EPS:
REV:
-0.64
37.599M
-1.46
24.35M
-1.19
16.871M
-18.49%
-30.71%
Q2 2017
Pre-Market
EPS:
REV:
-0.62
54.731M
-1.96
28.44M
-1.02
18.742M
-47.96%
-34.1%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!